HOOK News and Press, HOOKIPA Pharma Inc. From 12/26/19

No matter how much falls on us, we keep plowing ahead. That's the only way to keep the roads clear. "― Greg Kincaid Today we take a look at a ' Tier 4 ' developmental concern that came public in the second quarter of this year. The stock has had a big rally recently but is still ...

NEW YORK and VIENNA, Austria, Nov. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HO...

The following slide deck was published by HOOKIPA Pharma Inc. in conjunction with this Read more ...

Hookipa Pharma's (NASDAQ: HOOK ) vaccine technology, VaxWave and TheraT, are likely to revolutionize the prevention or cure of infectious disease and cancer and is currently undervalued. VaxWave, a replication deficient arenavirus modified for cell-specific targeting and to prevent the vector ...

HOOKIPA Pharma (NASDAQ: HOOK ): Q3 net loss of $11.38M. More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

NEW YORK and VIENNA, Austria, Nov. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reports its finan...

NEW YORK and VIENNA, Austria, Nov. 04, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, will announce financial...

NEW YORK and VIENNA, Austria, Oct. 31, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced its par...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...